Watertown, MA, United States of America

Raj Bandaru

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Curagen Corporation. Active years: 2005-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raj Bandaru. Retrieved from https://idiyas.com/inventor/raj-bandaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • New Haven, CT (US) (2005)
  • Watertown, MA (US) (2006)

Company Filing History:


Years Active: 2005-2006

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Raj Bandaru

Introduction

Raj Bandaru is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel human nucleic acid sequences and their applications. With a total of 2 patents, his work has implications for therapeutic and diagnostic methods.

Latest Patents

Raj Bandaru's latest patents include groundbreaking inventions related to polypeptides and polynucleotides homologous to thymosin, ephrin A receptors, and fibromodulin. These patents disclose novel human nucleic acid sequences that exhibit homology to important biological molecules. The inventions also encompass polypeptides encoded by these nucleic acid sequences, along with antibodies that specifically bind to the polypeptides. Furthermore, the patents detail derivatives, variants, mutants, or fragments of the aforementioned polypeptides, polynucleotides, or antibodies. The inventions provide therapeutic, diagnostic, and research methods for the diagnosis, treatment, and prevention of disorders associated with these novel nucleic acids and proteins.

Another significant patent by Raj Bandaru involves thymosin beta 10-like proteins and the nucleic acids encoding them. Similar to his previous work, this patent discloses novel human nucleic acid sequences and their encoded polypeptides. The associated antibodies and their derivatives are also included, along with methods for diagnosis, treatment, and prevention of related disorders.

Career Highlights

Raj Bandaru is currently associated with Curagen Corporation, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing our understanding of nucleic acids and their potential applications in medicine.

Collaborations

Throughout his career, Raj has collaborated with notable colleagues, including Sudhirdas K Prayaga and Raymond J Taupier, Jr. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Raj Bandaru's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…